SFM Clinical Research, LLC

Boca Raton, Florida 33487-2768

8 studies enrolling now · 20 studies all time

What they study most

Agitation Associated With Alzheimer's Dementia, Alzheimer Disease, Alzheimer's Disease, Generalized Myasthenia Gravis, MSA, MSA - Multiple System Atrophy, Myasthenia Gravis, Myasthenia Gravis, Generalized, Myasthenia Gravis, MuSK, Myasthenia Gravis, Ocular, Parkinson Disease, Parkinson Disease Psychosis

Studies at this site

• A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis — Recruiting now
• Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis — Recruiting now
• A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia — Recruiting now
• A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis — Recruiting now
• Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad) — Recruiting now
• Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis — Recruiting now
• A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa — Recruiting now
• A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis — Recruiting now
• A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis — Running, not enrolling
• A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis — Running, not enrolling
• To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications — Running, not enrolling
• Early Parkinson's Disease Monotherapy With CVN424 — Completed
• A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease — Stopped early
• A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis — Running, not enrolling
• Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy — Running, not enrolling
• Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG) — Running, not enrolling
• A Study of TAK-079 in People With Generalized Myasthenia Gravis — Completed
• Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure — Stopped early
• To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia — Stopped early
• The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study — Stopped early